Endoscopic management of sinonasal tumors: a preliminary report. Am J Rhinol 2005;19(3):307-15
Date
07/14/2005Pubmed ID
16011140Scopus ID
2-s2.0-21644479817 (requires institutional sign-in at Scopus site) 63 CitationsAbstract
BACKGROUND: The increased experience with the endoscopic approach to sinonasal inflammatory disease has resulted in the increased use of endoscopes to manage many different sinonasal pathologies.
METHODS: A chart review of patients with sinonasal tumors treated with primary endoscopic management, from January, 1993 to November, 2003 was performed.
RESULTS: Forty patients were identified (26 men and 14 women). The mean age was 53.2 years, and the mean follow-up was 31.1 months. For benign tumors, 24 patients were identified with a mean age of 50.7 years, a mean follow-up of 17.5 months, and a recurrence rate of 4.2%. For malignant tumors, 16 patients were identified, with a mean age of 57.3 years, a mean follow-up of 51.5 months, and a recurrence rate of 31.3%. The overall survival rate was 87.5%.
CONCLUSION: Endoscopic surgical excision of selective sinonasal tumors may be an effective therapeutic modality. In some cases, adjuvant external procedures may be required based on tumor location.
Author List
Poetker DM, Toohill RJ, Loehrl TA, Smith TLAuthors
Todd A. Loehrl MD Professor in the Otolaryngology department at Medical College of WisconsinDavid M. Poetker MD Chief, Professor in the Otolaryngology department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
AdenocarcinomaAdenoma
Adult
Aged
Aged, 80 and over
Angiofibroma
Carcinoma, Adenoid Cystic
Carcinoma, Squamous Cell
Chondrosarcoma
Endoscopy
Esthesioneuroblastoma, Olfactory
Female
Follow-Up Studies
Hemangiopericytoma
Humans
Male
Melanoma
Middle Aged
Nasal Cavity
Neoplasm Recurrence, Local
Osteoma
Papilloma, Inverted
Paranasal Sinus Neoplasms
Retrospective Studies
Survival Rate
Treatment Outcome
